Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-06, Stock:NVS, The news for the past five days is as follows:
2020-03-30: NEWS1: FDA Decisions on 5 Drugs Expected in 2nd Quarter.NEWS2: There’s scant evidence for chloroquine so far as a COVID-19 drug. But there’s already a shortage.NEWS3: Novartis Reports Data on Inclisiran, CHMP Positive on Zolgensma.NEWS4: FDA approves emergency use of malaria pill for COVID-19 treatment.
2020-03-31: NEWS1: The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie.NEWS2: The Biggest Biotech Is Expected To Grow — But Is It Enough To Be A Buy?.
2020-04-01: NEWS1: NVS vs. NVO: Which Stock Should Value Investors Buy Now?.
2020-04-02: NEWS1: Novartis Terminates Sale of Sandoz Dermatology Business.NEWS2: The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation.NEWS3: Novartis scraps sale of assets including COVID-19 hopeful to Aurobindo Pharma.
2020-04-03: NEWS1: Wilmington-based Incyte looking to repurpose flagship drug as COVID-19 treatment.NEWS2: Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In.NEWS3: Novartis Enlists Bone Marrow Cancer Drug in Fight Against Covid-19.NEWS4: A Cancer Drug From Incyte and Novartis Is Latest Potential Weapon Against Covid-19.NEWS5: The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO.NEWS6: Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19.

Answer: Rise